| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/18/2002 | CA2433981A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | CA2433960A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | CA2433813A1 Metabolic controlled fermentation process for carbamoyl tobramycin production |
| 07/18/2002 | CA2433652A1 Active metabolite of antifungal compound |
| 07/18/2002 | CA2433070A1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/18/2002 | CA2432350A1 Method for inhibiting the expression of a target gene |
| 07/18/2002 | CA2432319A1 Pulmonary delivery of polyene antifungal agents |
| 07/18/2002 | CA2432114A1 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | CA2429946A1 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | CA2428497A1 Targeted modification of intracellular compounds |
| 07/18/2002 | CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | CA2427840A1 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | CA2425625A1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 07/17/2002 | EP1223173A2 Novel 2'-O-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 07/17/2002 | EP1223166A1 Linked cyclic polyamines with activity against hiv. |
| 07/17/2002 | EP1222925A2 Kavalactone as TNF-alpha production inhibitor |
| 07/17/2002 | EP1222921A1 Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/17/2002 | EP1222683A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 07/17/2002 | EP1222302A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 07/17/2002 | EP1222300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222281A2 Immunoligically significant herpes simplex virus antigens |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222259A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 07/17/2002 | EP1222255A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222202A2 Ab5 toxin b subunit mutants with altered chemical conjug ation characteristics |
| 07/17/2002 | EP1222201A2 Peptides which stimulate the immune response and tissue regeneration |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP1222194A1 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222192A1 Hexahydrofuro[2,3-b]furan-3-yl-n- 3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222188A1 Novel imidazopyridine carbonitrile compounds |
| 07/17/2002 | EP1222186A2 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222170A1 Novel nicotinonitrile compounds |
| 07/17/2002 | EP1222169A1 Novel trisubstituted pyridine compounds |
| 07/17/2002 | EP1221985A1 Conveyance of anti-infective activity to wound dressings |
| 07/17/2002 | EP1221976A1 Low dose ifn-gamma for treatment of disease |
| 07/17/2002 | EP1221972A1 Plant lectins as mucosal adjuvants |
| 07/17/2002 | EP1221971A2 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 07/17/2002 | EP1221970A2 Compositions and methods for stimulating an immune response against infectious agents |
| 07/17/2002 | EP1221969A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221952A1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 07/17/2002 | EP1221950A1 Synergistic combinations of an nk 1? receptor antagonist and a gaba structural analog |
| 07/17/2002 | EP1221949A2 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 07/17/2002 | EP1221941A1 Powder pharmaceutical formulations |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP1221852A2 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 07/17/2002 | EP1083900B1 Use of of oxazolidinones for the preparation of a medicament for transdermal delivery |
| 07/17/2002 | EP1017392B1 Medicament formulation with a controlled release of an active agent |
| 07/17/2002 | EP1007086B1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/17/2002 | EP0915857B1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0876398B1 Induction of immune response against desired determinants |
| 07/17/2002 | EP0871638B1 Novel aminooligosaccharide derivative and process for preparing the same |
| 07/17/2002 | EP0863753B1 Use of perfluoroalkyl derivatives of amino acids as metallo-beta-lactamase inhibitors |
| 07/17/2002 | EP0817637B1 Synergistic combinations of zidovudine, 1592u89 and 3tc |
| 07/17/2002 | EP0749452B1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359392A Coupled compound of erythropoietin with glycol |
| 07/17/2002 | CN1359386A Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 07/17/2002 | CN1359300A Uro-genital condition treatment system |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/17/2002 | CN1359290A Medicinal compositions for preventing or treating viral myocarditis |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1359262A Therapeutic anti-fungal nail preparation |
| 07/17/2002 | CN1358734A 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
| 07/17/2002 | CN1358730A Oligose capable of being used as medicine and its surfated products and preparation process thereof, and medicinal composition having same |
| 07/17/2002 | CN1358720A Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity |
| 07/17/2002 | CN1358716A Substituted benzopyran anti-fungus compound |
| 07/17/2002 | CN1358539A Ointment for treating ulcer and hyperplastic skin and preparation process |
| 07/17/2002 | CN1358537A Medicine for treating skin disease and preparation process |
| 07/17/2002 | CN1358536A Medicine for treating lymphatic tuberculosis and lymphoma |
| 07/17/2002 | CN1358530A Litholytic medicine for treating hepatolith and preparation process thereof |
| 07/17/2002 | CN1358524A Spraying medicine for treating tinea pedis and process for making same |
| 07/17/2002 | CN1358521A Liquid medicine for treating beriberi |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087624C Chinese-medicina decoction for treating lung diseases |
| 07/17/2002 | CN1087608C Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420571 Methods for preparing antiviral calanolide compounds |
| 07/16/2002 | US6420554 Process for preparation of 3-cephem compound |
| 07/16/2002 | US6420551 Antisense oligonucleotides targeted against human immunodeficiency virus |
| 07/16/2002 | US6420546 Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420538 Aromatic amides, preparation method and application as medicines |
| 07/16/2002 | US6420537 Generating azithromycins; obtain preferential erythromycin derivative, methylate in the presence of formaldehyde and reducing agent, recover azithromycins |
| 07/16/2002 | US6420536 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 07/16/2002 | US6420431 Methods for treating disordered tissue through agitated delivery of anti-infective compositions |
| 07/16/2002 | US6420421 Alkyl-dimethyl-benzyl or ethylbenzyl ammonium chloride mixture and bis(tri-n-butyltin)oxide; used to treat viral, bacterial and fungal infections in mammals and avians |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |